CD33 and glioblastoma: The frequencies of CD11b+ CD33+ cells in GBM TILs were on average higher compared to GBM PBMCs, and were significantly higher than of HD PBMCs (Figure 6C and Supplemental Figure 2C), suggesting that MDSCs are present at high levels in GBM and could contribute to the TME immunosuppression (46).